Mometasona Korhispana (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Korhispana, is a corticosteroid (topical glucocorticoid) presented as a topical formulation for cutaneous use. It treats inflammatory skin conditions such as atopic dermatitis, psoriasis, contact dermatitis and seborrheic dermatitis in adults and children as directed by a healthcare professional.

GNH USA supplies Mometasona Korhispana as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a potent topical glucocorticoid used to manage inflammatory skin disorders. - Atopic dermatitis: reduces redness, itching and swelling in chronic eczema. - Psoriasis: diminishes plaque formation and scaling. - Contact dermatitis: alleviates irritation caused by allergens or irritants. - Seborrheic dermatitis: controls flaking and erythema on scalp and face.

Topical application of mometasone furoate may be associated with local and systemic adverse reactions.

Common Side Effects: - Burning or stinging at the application site. - Pruritus or mild irritation. - Dryness or peeling of the skin. - Erythema or mild redness. - Folliculitis. - Acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Telangiectasia (visible small blood vessels). - Hypopigmentation or hyperpigmentation. - Secondary infection (bacterial, fungal, viral). - Systemic corticosteroid effects (e.g., adrenal suppression) with extensive use. - Allergic contact dermatitis to the formulation.

Before using Mometasona Korhispana, consider the following safety measures. - Apply only to intact skin: avoid broken, infected or ulcerated areas. - Limit duration: use for the shortest period necessary to control symptoms. - Avoid occlusion: do not cover treated area with airtight dressings unless directed. - Pediatric use: follow pediatric dosing guidelines and monitor for growth effects. - Systemic absorption: be cautious in extensive body‑surface application or in patients on other steroids. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Mometasone furoate may interact with other agents that affect corticosteroid metabolism or skin integrity.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use can increase risk of systemic side effects. - Potent CYP3A4 inhibitors (e.g., ketoconazole cream): may raise local drug levels.

Moderate Interactions (Monitor Closely): - Antifungal or antibacterial topical agents: monitor for irritation or altered absorption. - Skin‑lightening agents (e.g., hydroquinone): may increase risk of hypopigmentation. - Immunosuppressants: watch for heightened infection risk. - Occlusive dressings: may enhance systemic absorption. - Phototherapy: assess for additive skin‑irritation effects.